SCHEMBL6286068

SCHEMBL6286068

C[Si](C)(C)CCOCn1nc(C=Cc2ccc3c(c2)OCO3)c2c([N+](=O)[O-])cccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
MTOR P42345 1/20 0.39
VCP P55072 1/20 0.39
MAPT P10636 5/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
HPGD P15428 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PTPN1 P18031 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.34
CYP19A1 P11511 1/20 0.34
ALDH1A1 P00352 3/20 0.34
ATM Q13315 1/20 0.34
DDX3X O00571 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6282634 0.85 SMN1; SMN2 (0.38) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL5247115 0.82 PTPN1 (0.41) KDM4ENPC1RAB9AMTORVCP
SCHEMBL5247119 0.82 PTPN1 (0.41) KDM4ENPC1RAB9AMTORVCP
SCHEMBL6492444 0.82 SMN1; SMN2 (0.37) NPC1RAB9AMTORVCPMAPT
SCHEMBL6760466 0.80 SMN1; SMN2 (0.38) NPC1RAB9AMTORVCPMAPT
SCHEMBL6760468 0.80 SMN1; SMN2 (0.38) NPC1RAB9AMTORVCPMAPT
SCHEMBL5249416 0.79 SMN1; SMN2 (0.39) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL5249412 0.79 SMN1; SMN2 (0.39) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL5247160 0.79 KDR (0.45) NPC1RAB9AMAPTSMN1; SMN2PTPN1
SCHEMBL5247154 0.77 SMN1; SMN2 (0.43) MAPTSMN1; SMN2KMT2AMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6891044-B2 Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use AGOURON PHARMACEUTICALS, INC. (US) 2005-05-10 US disclosed